SELLAS LIFE SCIENCES GROUP I's ticker is SLS and the CUSIP is 81642T209. A total of 31 filers reported holding SELLAS LIFE SCIENCES GROUP I in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,700,526 | +14.4% | 1,036,906 | +9.5% | 0.00% | – |
| Q2 2023 | $1,486,332 | +15.9% | 946,708 | +5.6% | 0.00% | – |
| Q1 2023 | $1,282,584 | -36.5% | 896,912 | +4.8% | 0.00% | – |
| Q4 2022 | $2,020,358 | +20.5% | 856,084 | +3.1% | 0.00% | – |
| Q3 2022 | $1,677,000 | -9.4% | 830,119 | 0.0% | 0.00% | – |
| Q2 2022 | $1,851,000 | -57.8% | 830,119 | +26.4% | 0.00% | – |
| Q1 2022 | $4,388,000 | +21.2% | 656,919 | +0.4% | 0.00% | – |
| Q4 2021 | $3,619,000 | -39.3% | 654,562 | +0.5% | 0.00% | – |
| Q3 2021 | $5,966,000 | -13.1% | 651,283 | +5.3% | 0.00% | – |
| Q2 2021 | $6,866,000 | +71.1% | 618,534 | +31.6% | 0.00% | – |
| Q1 2021 | $4,013,000 | +19.7% | 469,853 | -18.6% | 0.00% | – |
| Q4 2020 | $3,353,000 | +836.6% | 577,064 | +327.1% | 0.00% | – |
| Q3 2020 | $358,000 | -23.2% | 135,108 | -15.1% | 0.00% | – |
| Q2 2020 | $466,000 | +69.5% | 159,108 | 0.0% | 0.00% | – |
| Q1 2020 | $275,000 | -60.0% | 159,108 | -0.4% | 0.00% | – |
| Q4 2019 | $687,000 | – | 159,798 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $1,787,500 | 0.02% |
| Alyeska Investment Group, L.P. | 1,000,000 | $1,430,000 | 0.01% |
| Opus Capital Group, LLC | 25,000 | $36 | 0.01% |
| Equitable Holdings, Inc. | 130,000 | $185,900 | 0.00% |
| VANGUARD GROUP INC | 896,912 | $1,282,584 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,660 | $2,373 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 31,304 | $44,765 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16,142 | $23,083 | 0.00% |
| NORTHERN TRUST CORP | 30,018 | $42,926 | 0.00% |